Enalapril maleate 1 MG/ML Oral Solution — RxCUI 1435624
RxNorm drug concept · Semantic clinical drug
RxCUI 1435624
Semantic clinical drug · SCD
● Current RxNorm concept 9 FDA products
9 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1435624
Official nameEnalapril maleate 1 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asenalapril maleate 1 MG per 1 ML Oral Solution; enalapril maleate 1 MG in 1 mL Oral Solution
FDA products mapped9
Package NDCs mapped9
Reported Medicaid activity (SDUD)47,571 prescriptions · 49 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Enalapril: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Enalapril is mainly used for three things: lowering high blood pressure, treating heart failure when you have symptoms like breathlessness or fatigue, and treating a condition wher...
- A dry, persistent cough is one of the most common side effects of enalapril and other ACE inhibitors — it affects some people more than others. If the cough becomes bothersome, let...
- No — enalapril is not safe during pregnancy. It can seriously injure or even cause the death of an unborn baby, especially in the second and third trimesters. If you're planning a...
- Is it safe to take enalapril if I'm pregnant or trying to get pregnant?
🕸️ Concept Web — How Enalapril maleate 1 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Enalapril maleate 1 MG/ML Oral Solution
RxCUI 1435624 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Enalapril
3827IN -
Enalapril maleate
203123PIN
-
Enalapril
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Epaned
1435625BN
-
Epaned
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Enalapril Oral Solution
1435623SCDF -
Enalapril maleate Oral Solution
2645779SCDFP -
Enalapril Oral Liquid Product
1435622SCDG -
Enalapril Oral Product
1162652SCDG -
Enalapril maleate Oral Liquid Product
2660886SCDGP -
Enalapril maleate Oral Product
2661893SCDGP -
Enalapril Oral Solution [Epaned]
1435627SBDF -
Enalapril maleate Oral Solution [Epaned]
2658821SBDFP - +5 more in this family
-
Enalapril Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Enalapril maleate 1 MG/ML
1435621SCDC -
Enalapril maleate 1 MG/ML Oral Solution [Epaned]
1435630SBD -
Enalapril maleate 1 MG/ML [Epaned]
1435626SBDC
-
Enalapril maleate 1 MG/ML
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Enalapril maleate 1 MG/ML
SCDC · 1435621 -
Enalapril Oral Solution
SCDF · 1435623 -
Enalapril maleate Oral Solution
SCDFP · 2645779 -
Enalapril Oral Liquid Product
SCDG · 1435622 -
Enalapril Oral Product
SCDG · 1162652 -
Enalapril maleate Oral Liquid Product
SCDGP · 2660886 -
Enalapril maleate Oral Product
SCDGP · 2661893
Brand-Name Concepts
-
Enalapril maleate 1 MG/ML Oral Solution [Epaned]
SBD · 1435630 -
Enalapril maleate 1 MG/ML [Epaned]
SBDC · 1435626 -
Enalapril Oral Solution [Epaned]
SBDF · 1435627 -
Enalapril maleate Oral Solution [Epaned]
SBDFP · 2658821 -
Epaned Oral Liquid Product
SBDG · 1435628 -
Epaned Oral Product
SBDG · 1435629 -
Epaned
BN · 1435625
📦 FDA Products & Package NDCs
9 products · 9 package NDCs
9 package NDCs map to RxCUI 1435624 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 31722-0020-15 | 1 BOTTLE in 1 CARTON (31722-020-15) / 150 mL in 1 BOTTLE | Enalapril maleate oral solution | Camber Pharmaceuticals, Inc. | 2022-02-14 |
| 52536-0401-01 | 1 BOTTLE in 1 CARTON (52536-401-01) / 150 mL in 1 BOTTLE | Enalapril maleate | Wilshire Pharmaceuticals, Inc. | 2024-04-08 |
| 52652-4001-01 | 150 mL in 1 BOTTLE (52652-4001-1) | Epaned | Azurity Pharmaceuticals, Inc. | 2016-10-03 |
| 59651-0529-55 | 1 BOTTLE in 1 CARTON (59651-529-55) / 150 mL in 1 BOTTLE | ENALAPRIL MALEATE | Aurobindo Pharma Limited | 2024-01-08 |
| 67877-0712-81 | 150 mL in 1 BOTTLE (67877-712-81) | Enalapril Maleate Oral Solution | Ascend Laboratories, LLC | 2022-09-05 |
| 69238-1729-07 | 1 BOTTLE in 1 CARTON (69238-1729-7) / 150 mL in 1 BOTTLE | Enalapril Maleate | Amneal Pharmaceuticals NY LLC | 2019-12-01 |
| 69238-2141-07 | 1 BOTTLE in 1 CARTON (69238-2141-7) / 150 mL in 1 BOTTLE | Enalapril Maleate | Amneal Pharmaceuticals NY LLC | 2022-03-23 |
| 69452-0237-46 | 1 BOTTLE in 1 CARTON (69452-237-46) / 150 mL in 1 BOTTLE | Enalapril maleate oral solution | Bionpharma Inc. | 2021-08-11 |
| 72603-0247-01 | 1 BOTTLE in 1 CARTON (72603-247-01) / 150 mL in 1 BOTTLE | Enalapril maleate oral solution | NorthStar RxLLC | 2024-05-01 |
Observed labelers:
Amneal Pharmaceuticals NY LLC (2) ·
Ascend Laboratories, LLC (1) ·
Aurobindo Pharma Limited (1) ·
Azurity Pharmaceuticals, Inc. (1) ·
Bionpharma Inc. (1) ·
Camber Pharmaceuticals, Inc. (1)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.9921
Range $0.9921–$4.4792
· middle 50% $0.9921–$0.9921
· 8 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.